$20.23
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

OrthoPediatrics Corp. is an orthopedic company, which engages in the design, development, and marketing of anatomically appropriate implants and devices for children with orthopedic conditions. The company is headquartered in Warsaw Indiana, Indiana and currently employs 602 full-time employees. The company went IPO on 2017-10-12. The firm is engaged in designing, developing, and marketing anatomically appropriate implants and devices for children with orthopedic conditions, giving pediatric orthopedic surgeons and caregivers. The firm sells its specialized products, including PediLoc, PediPlates, Cannulated Screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruction System, Locking Cannulated Blade, Locking Proximal Femur, Spica Tables, RESPONSE Spine, BandLoc, Devise Rail, Orthex, The Fassier-Duval Telescopic Intramedullary System, SLIM Nail, The GAP Nail, The Free Gliding SCFE Screw System, GIRO Growth Modulation System, PNP Tibia System, ApiFix Mid-C System and Mitchell Ponset specialized bracing products to various hospitals and medical facilities throughout the United States and various international markets. The company markets 80 surgical and specialized bracing systems.
Country

US

CEO

Mr. David Bailey

IPO date

2017

Employees

602

ISIN

US68752L1008

Key stats

Open

$19.72

Volume

84.55K

Market cap

$507.54M

Prev. close

$20.23

Impl / hst vl

-

Open interest

$0.00

$19.38

Day’s Range

$20.25

$14.42

52W Range

$21.40

Valuation

61
Valuation score
Undervalued
P/E
-
P/S
2.09
P/B
1.50
Current ratio
5.21
Debt / Equity
0.15
ROE
-11.42%
Gross margin
73.09%
Income growth
5.78%
FCF growth
-151.77

Analysts estimates

Consensus rating
Buy

The average rating from top 9 analysts indicates that stock is expected to perform in line with the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$25.16
The top 11 analysts forecasts that 12-month price may increase by 24.37%, with a low of $17.17 and a high of $35.70
$17.17
Low
$25.16
Avg
$35.70
High
Current price

Earnings

Q1 ‘26 revenue
$59.36M
Q1 ‘26 net income
-$10.69M
Revenue
Net income
Previous EPS
-$0.45
Estimate EPS
-$0.31
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply